Advertisement

Related Videos

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Peter Clark, MA, MD, FRCP: A Payer Perspective

Robin Feldman, JD: Are Dubious Patents a Large or Small Issue?

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Advertisement

Advertisement




May
04
Today In Oncology
Addition of Perioperative Pembrolizumab to Standard of Care in Newly Diagnosed Locally Advanced Head and Neck Cancer
Dose Escalation of Fluorodeoxyglucose PET Guided Radiotherapy for Locally Advanced NSCLC
Use of CAD CAM May Improve Jaw Reconstruction Outcomes Among Patients With Head and Neck Cancer
Adavosertib in Recurrent or Persistent Uterine Serous Carcinoma
Applications Are Now Open for the 2025 Integrative Oncology Scholars Program and Integrative Oncology Fellows Program
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo